Advances in migraine management.
New drugs and better understanding of the pathogenesis of migraine are improving the outlook for patients with this debilitating disorder. This paper reviews recent advances and outlines our approach.
Lewis
T A
TA
Department of Internal Medicine, Cleveland Clinic Foundation, OH 44195, USA.
Solomon
G D
GD
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000627:therapeutic use; D001676:Biofeedback, Psychology; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D003131:Combined Modality Therapy; D005544:Forecasting; D006801:Humans; D008487:Medical History Taking; D008881:Migraine Disorders / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*; D014635:Valproic Acid / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D000894:Anti-Inflammatory Agents, Non-Steroidal; D000928:Antidepressive Agents; D002121:Calcium Channel Blockers; D014635:Valproic Acid